[ Trusted Worldwide ]

Partnering Globally

Graviti’s International Business division delivers high-quality, compliant pharmaceutical products globally through strategic partnerships and regulatory excellence. With filings underway in the UK and Europe, and world-class manufacturing aligned with USFDA and WHO-GMP standards, we ensure agile development and seamless commercialization—advancing healthcare access and value across borders.​


Why choose Graviti pharma generics?​

Global Regulatory Compliance

Our generics are manufactured in state-of-the-art facilities that comply with USFDA, WHO-GMP, and other stringent regulatory authorities, ensuring safety, efficacy, and quality at every step.

Wide Therapeutic Coverage

We offer a broad portfolio of generics across key therapeutic areas—Cardiovascular, Diabetes, Antibiotics, CNS (Central Nervous System), and more—addressing major global health challenges.

Cardiovascular – Advanced therapies for heart health
Diabetes – Effective solutions for glycemic control
Antibiotics – Combatting bacterial infections
CNS (Central Nervous System) – Treatments for neurological and psychiatric conditions

Cutting-edge R&D

Through continuous innovation and investment in research, we develop bioequivalent generics that meet the highest standards of quality, stability, and therapeutic effectiveness.